| payload |
{"artifact_id":"artf_thesis_35201b1a72 {"artifact_id":"artf_thesis_35201b1a72c5121e","evidence_event_ids":["evt_b4e7e98a8309"],"kind":"opportunity_thesis","meta":{"confidence":0.3695,"lane":"monitor","morning_holdback":false,"rank_score":0.3695,"theme_keys":[],"urgency_reason":"not_urgent","urgent":false},"output_json":{"artifact_kind_detail":"research_thesis","catalysts":[],"confidence":0.3695,"decision_reason_codes":["research_thesis"],"headline":"Tango Therapeutics, Inc. filed Form 4 (accession 0001193125-26-159747) on 2026-04-16 for transactions dated 2026-04-15 by reporting owner Crystal Adam under a Rule 10b5-1 trading plan.","investigation_questions":["The cleaned text does not clearly show the specific transaction type(s) (e.g., buy/sell) and the exact number of shares/options transacte...","The signal is labeled \u201cdiscovery_sec_filing_delta,\u201d but no prior known state or comparison details are provided in the input, so \u201cwhat ch..."],"portfolio_fit":{"applied":false,"boost":0.0,"exit_risk_flagged":false,"hedge_suggested":null,"matched_holdings":[],"matched_watchlist":[],"stub_version":"v1","why_you":""},"related_tickers":["TNGX"],"risk_level":"medium","theme_keys":[],"thesis":"Form 4 \u00b7 Tango Therapeutics, Inc. \u00b7 Filed 20260416; SEC filing accession number: 0001193125-26-159747.; Form type: 4 (Form 4). \u2014 Signal convergence: Tango Therapeutics, Inc. filed Form 4 (accession 0001193125-26-159747) on 2026-04-16 for transactions dated 2026-04-15 by reporting owner Crystal Adam under a Rule 10b5-1 trading plan. [neutral]"},"ready_at":"2026-04-17T06:47:14.275275+00:00","status":"ready","summary":"Form 4 \u00b7 Tango Therapeutics, Inc. \u00b7 Filed 20260416; SEC filing accession number: 0001193125-26-159747.; Form type: 4 (Form 4). \u2014 Signal convergence: Tango Therapeutics, Inc. filed Form 4 (accession 0001193125-26-159747) on 2026-04-16 for transactions dated 2026-04-15 by reporting owner Crystal Adam under a Rule 10b5-1 trading plan. [neutral]","title":"[THESIS] TNGX \u2014 Tango Therapeutics, Inc. filed Form 4 (accession 0001193125-26-159747) on 2026-04-16 for transactions dated 2026-04-15 by reporting owner Crystal Adam under a Rule 10b5-1 trading plan.","updated_at":"2026-04-17T06:47:14.275275+00:00"}... |